TMBIM4 and neurodegenerative disease: Donepezil–flavonoid hybrids represent a paradigm shift in neurodegenerative disease treatment, merging the cognitive benefits of acetylcholinesterase inhibition with flavonoid-derived antioxidant, anti-inflammatory, and S1R-mediated neuroprotection.